Search results
Results From The WOW.Com Content Network
In Germany, several laws govern drugs (both recreational and pharmaceutical). Narcotic Drugs Act (Betäubungsmittelgesetz, BtMG), regulates narcotics and contains explicit lists of those covered: Anlage I (authorized scientific use only), Anlage II (authorized trade only, not prescriptible) and Anlage III (special prescription form required ...
The following drugs are controlled by the German Narcotic Drugs Act (German: Betäubungsmittelgesetz or BtMG). Trade and possession of these substances without licence or prescription is considered illegal; prescription is illegal for drugs on Anlage I and II and drugs on Anlage III require a special prescription form.
[4] [5] The Bundestag passed the bill on 23 February 2024, and the Bundesrat approved it on 22 March, with the national legalisation to follow by 1 April. [ 6 ] [ 7 ] The final bill legislates that adults in Germany (those aged 18 and over) can legally use cannabis, possess and carry up to 25 grams ( 7 ⁄ 8 oz) of cannabis for personal ...
The BtMG updated the German Opium Law 1929 and mirrors the Swiss BtMG and Austrian Suchtmittelgesetz. The German Narcotics Act was re-announced on 1 March 1994. [2] The last change to the law was the legalization of Cannabis in Germany on 1 April 2024. Since then, the handling of this drug has been subject to the German cannabis control bill. [3]
Drug and precursor laws Germany: Anlage I [8] Anlage II [9] Anlage III [10] Sweden: Narkotikastrafflagen. Läkemedelsverkets föreskrifter om förteckningar över narkotika [11] Lagen om förbud mot vissa hälsofarliga varor. List of substances [12] Kontroll av narkotikaprekursorer [permanent dead link ] (up to date list of laws) New Zealand ...
Louisiana's current chemical castration law has been in place since 2008, however very few offenders have had the punishment passed handed down to them — with officials saying from 2010 to 2019 ...
In the 2023-24 academic year, 115 out of 159 school systems — or 72.3% — reported zero incidents of seclusion and restraint. Over a six-year period, 89 school systems (56.0%) reported no i
This list is not limited to drugs that were ever approved by the FDA. Some of them (lumiracoxib, rimonabant, tolrestat, ximelagatran and ximelidine, for example) were approved to be marketed in Europe but had not yet been approved for marketing in the US, when side effects became clear and their developers pulled them from the market.